Twelve Israeli travelers acquired schistosomiasis in Laos during 2002-2008, and 7 of them had acute schistosomiasis. The patients were probably exposed to Schistosoma mekongi in southern Laos, an area known to be endemic for schistosomiasis. Four possibly were infected in northern Laos, where reports of schistosomiasis are rare.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857239 | PMC |
| http://dx.doi.org/10.3201/eid1511.090611 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Approach to skin problems in travellers: clinical and epidemiological clues.
J Travel Med
December 2024
Infectious and Tropical Diseases, Sorbonne University, Faculté de médecine, Hôpitaux Universitaires Pitié Salpêtrière, Boulevard de l'Hôpital, 75013, Paris, France.
Article Synopsis
- Travelers often experience skin problems requiring medical attention, with proper diagnosis relying on clinical examinations and understanding travel history and behaviors.* -
- The most common travel-related skin issues include insect bites, sunburns, and infections like hookworm and bacteria, with specific diseases like dengue fever and schistosomiasis being noteworthy.* -
- Evaluating skin conditions involves considering travel history, activities, and specific lesion characteristics, which help identify risks and guide treatment.*
Imported schistosomiasis in travelers: Experience from a referral tropical medicine unit in Barcelona, Spain.
Travel Med Infect Dis
July 2024
International Health Unit Vall d'Hebron-Drassanes, Infectious Diseases Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Background: Acute schistosomiasis occurs most often in travelers to endemic regions. The aim of the study is to describe the epidemiological, clinical and parasitological characteristics of patients with schistosomiasis acquired during an international travel.
Methods: Observational retrospective study including all travel-related schistosomiasis cases seen at the International Health Unit Vall d'Hebron-Drassanes (Barcelona, Spain) from 2009 to 2022.
Surveillance cystoscopy for atypical Schistosoma haematobium infection associated with recurrent UTIs.
Travel Med Infect Dis
May 2024
Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Thai Travel Clinic, Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Evaluation of the accuracy of a multi-infection screening test based on a multiplex immunoassay targeting imported diseases common in migrant populations.
Travel Med Infect Dis
January 2024
Barcelona Institute for Global Health (ISGlobal), Hospital Clínic-Universitat de Barcelona, Carrer Roselló 132, 08036, Barcelona, Spain; Biomedical Research Networking Center (CIBER) of Infectious Diseases, Carlos III Health Institute (CIBERINFEC, ISCIII), Carrer Melchor Fernández Almagro, 3, 28029, Madrid, Spain; Department of Medicine Solna, Karolinska Institutet, Solnavägen 1, 17177, Solna-Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Solnavägen 1, 17177, Solna-Stockholm, Sweden. Electronic address:
Background: We aimed to evaluate the performance of a novel multiplex serological assay, able to simultaneously detect IgG of six infections, as a screening tool for imported diseases in migrants.
Methods: Six panels of 40 (n = 240) anonymized serum samples with confirmed infections were used as positive controls to assess the multiplex assay's sensitivity. One panel of 40 sera from non-infected subjects was used to estimate the seropositivity cutoffs, and 32 non-infected sera were used as negative controls to estimate each serology's sensitivity and specificity.
COVID-19 impact on EuroTravNet infectious diseases sentinel surveillance in Europe.
Travel Med Infect Dis
June 2023
WHO Collaborating Centre for Travellers' Health, Department of Global and Public Health, Epidemiology, Biostatistics and Prevention Institute, University of Zürich, Zürich, Switzerland.
Background: The COVID-19 pandemic resulted in a sharp decline of post-travel patient encounters at the European sentinel surveillance network (EuroTravNet) of travellers' health. We report on the impact of COVID-19 on travel-related infectious diseases as recorded by EuroTravNet clinics.
Methods: Travelers who presented between January 1, 2019 and September 30, 2021 were included.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!